FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1979393217> ?p ?o ?g. }

• W1979393217 endingPage "89" @default.
• W1979393217 startingPage "75" @default.
• W1979393217 abstract "Although elucidation of the medicinal chemistry of agonists and antagonists of the P2Y receptors has lagged behind that of many other members of group A G protein-coupled receptors, detailed qualitative and quantitative structure-activity relationships (SARs) were recently constructed for several of the subtypes. Agonists selective for P2Y(1), P2Y(2), and P2Y(6) receptors and nucleotide antagonists selective for P2Y(1) and P2Y(12) receptors are now known. Selective nonnucleotide antagonists were reported for P2Y(1), P2Y(2), P2Y(6), P2Y(11), P2Y(12), and P2Y(13) receptors. At the P2Y(1) and P2Y(12) receptors, nucleotide agonists (5'-diphosphate derivatives) were converted into antagonists of nanomolar affinity by altering the phosphate moieties, with a focus particularly on the ribose conformation and substitution pattern. Nucleotide analogues with conformationally constrained ribose-like rings were introduced as selective receptor probes for P2Y(1) and P2Y(6) receptors. Screening chemically diverse compound libraries has begun to yield new lead compounds for the development of P2Y receptor antagonists, such as competitive P2Y(12) receptor antagonists with antithrombotic activity. Selective agonists for the P2Y(4), P2Y(11), and P2Y(13) receptors and selective antagonists for P2Y(4) and P2Y(14) receptors have not yet been identified. The P2Y(14) receptor appears to be the most restrictive of the class with respect to modification of the nucleobase, ribose, and phosphate moieties. The continuing process of ligand design for the P2Y receptors will aid in the identification of new clinical targets." @default.
• W1979393217 created "2016-06-24" @default.
• W1979393217 creator A5030808105 @default.
• W1979393217 creator A5047973449 @default.
• W1979393217 creator A5074200367 @default.
• W1979393217 creator A5075179551 @default.
• W1979393217 creator A5091587615 @default.
• W1979393217 date "2008-07-04" @default.
• W1979393217 modified "2023-10-14" @default.
• W1979393217 title "Development of selective agonists and antagonists of P2Y receptors" @default.
• W1979393217 cites W1573846225 @default.
• W1979393217 cites W1608256683 @default.
• W1979393217 cites W1952796400 @default.
• W1979393217 cites W1964394684 @default.
• W1979393217 cites W1965737095 @default.
• W1979393217 cites W1965982516 @default.
• W1979393217 cites W1967490656 @default.
• W1979393217 cites W1969233019 @default.
• W1979393217 cites W1970811141 @default.
• W1979393217 cites W1974468894 @default.
• W1979393217 cites W1977267867 @default.
• W1979393217 cites W1980927246 @default.
• W1979393217 cites W1981183509 @default.
• W1979393217 cites W1985927027 @default.
• W1979393217 cites W1986775812 @default.
• W1979393217 cites W1989231358 @default.
• W1979393217 cites W1989545734 @default.
• W1979393217 cites W1990957524 @default.
• W1979393217 cites W1991341552 @default.
• W1979393217 cites W1992600646 @default.
• W1979393217 cites W1997332036 @default.
• W1979393217 cites W1997884817 @default.
• W1979393217 cites W1998879670 @default.
• W1979393217 cites W1999018790 @default.
• W1979393217 cites W2000595484 @default.
• W1979393217 cites W2001777306 @default.
• W1979393217 cites W2007899163 @default.
• W1979393217 cites W2008975884 @default.
• W1979393217 cites W2009969591 @default.
• W1979393217 cites W2010428132 @default.
• W1979393217 cites W2012894470 @default.
• W1979393217 cites W2015188445 @default.
• W1979393217 cites W2024250469 @default.
• W1979393217 cites W2025781453 @default.
• W1979393217 cites W2026271678 @default.
• W1979393217 cites W2028652800 @default.
• W1979393217 cites W2029400868 @default.
• W1979393217 cites W2030963075 @default.
• W1979393217 cites W2031797534 @default.
• W1979393217 cites W2034517529 @default.
• W1979393217 cites W2034756826 @default.
• W1979393217 cites W2037935243 @default.
• W1979393217 cites W2041904720 @default.
• W1979393217 cites W2044304093 @default.
• W1979393217 cites W2044745250 @default.
• W1979393217 cites W2045630272 @default.
• W1979393217 cites W2050417355 @default.
• W1979393217 cites W2054924316 @default.
• W1979393217 cites W2055808642 @default.
• W1979393217 cites W2057580379 @default.
• W1979393217 cites W2059907882 @default.
• W1979393217 cites W2060258953 @default.
• W1979393217 cites W2063397342 @default.
• W1979393217 cites W2063572131 @default.
• W1979393217 cites W2064566190 @default.
• W1979393217 cites W2068613384 @default.
• W1979393217 cites W2071093592 @default.
• W1979393217 cites W2074943318 @default.
• W1979393217 cites W2081583827 @default.
• W1979393217 cites W2081758042 @default.
• W1979393217 cites W2082172093 @default.
• W1979393217 cites W2082228501 @default.
• W1979393217 cites W2086468552 @default.
• W1979393217 cites W2087153895 @default.
• W1979393217 cites W2088530528 @default.
• W1979393217 cites W2096405956 @default.
• W1979393217 cites W2096789499 @default.
• W1979393217 cites W2100452437 @default.
• W1979393217 cites W2101051657 @default.
• W1979393217 cites W2113076620 @default.
• W1979393217 cites W2123382745 @default.
• W1979393217 cites W2132293504 @default.
• W1979393217 cites W2150811182 @default.
• W1979393217 cites W2160290045 @default.
• W1979393217 cites W2170816637 @default.
• W1979393217 cites W2180780341 @default.
• W1979393217 cites W2338849580 @default.
• W1979393217 cites W2952734518 @default.
• W1979393217 cites W299010878 @default.
• W1979393217 cites W4244975743 @default.
• W1979393217 cites W4250133902 @default.
• W1979393217 doi "https://doi.org/10.1007/s11302-008-9106-2" @default.
• W1979393217 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2721770" @default.
• W1979393217 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18600475" @default.
• W1979393217 hasPublicationYear "2008" @default.
• W1979393217 type Work @default.
• W1979393217 sameAs 1979393217 @default.
• W1979393217 citedByCount "97" @default.

• next